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Abstract 
In this thesis I present the key projects and activities completed as part of the Australian 
National University’s Master of Philosophy in Applied Epidemiology (MAE) program during my 
candidature in 2018-2019. 
During my candidature I was based in the Communicable Disease Epidemiology and 
Surveillance (CDES) unit at the Victorian Department of Health and Human Services (DHHS), 
and the Surveillance and Evaluation group at the Burnet Institute in Melbourne, Victoria, 
Australia. I completed four major projects across these two organisations, as well as being 
involved with a range of other infectious disease surveillance and research activities. 
At DHHS, I was involved in the investigation of a large, complex cluster of tuberculosis cases in 
a Pacific Island cultural community. This three-year investigation was one of the largest 
tuberculosis cluster investigations ever undertaken by the Department of Health and Human 
Services and the Victorian Tuberculosis Program. The epidemiological side of the investigation 
in which I was involved utilised epidemiological, social-location and genomic data to better 
understand transmission within this complex cluster. 
I also conducted an epidemiological study of delays in patient presentation and diagnosis for 
Buruli ulcer in Victoria. Given the current lack of effective interventions to reduce disease 
transmission in Victoria, prompt diagnosis and treatment are critical to minimise the impact of 
the disease. The study aimed to characterise and identify factors influencing presentation and 
diagnosis delays in patients notified to DHHS between 2011 and 2017 to better inform public 
health messaging for the public and medical practitioners. The study was published in the 
Tropical Medicine and Infectious Diseases journal in July 2019 and presented at the National 
Centre for Epidemiology and Population Health Seminar Series in February 2019. The 
published article forms the body of the relevant chapter in this thesis. 
At the Burnet Institute I completed an evaluation of the Australian Collaboration for the 
Coordinated Enhanced Surveillance of Blood-Borne Viruses (BBVs) and Sexually Transmissible 
Infections (STIs) (ACCESS), a sentinel surveillance system for STIs and BBVs funded by the 
Australian Government Department of Health to expand nationally between 2016-2019. Based 
on the outcomes of the evaluation, I made several recommendations to improve the operation 
of ACCESS during the next potential funding period. The findings of this evaluation were 
provided to the Australian Government Department of Health as part of the final project 
deliverables for the funding period. 
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My data analysis project at the Burnet Institute examined the epidemiology and subtype 
diversity of HIV-1 in newly-arrived Asian-born and Australian-born men who have sex with 
men (MSM) populations in Victoria using routinely-collected surveillance and subtyping data. 
Understanding and addressing HIV transmission in the newly-arrived Asian-born MSM 
population is increasingly important in Victoria, with both the population and the proportion 
of HIV notifications from the population increasing in recent years. This study was presented as 
an invited oral presentation at the International Union Against Sexual Transmitted Infections 
Asia-Pacific Conference in Shanghai, China in October 2019. A manuscript based on this project 
has been submitted for review to the peer-reviewed journal Sexual Health – this late-draft 
manuscript is presented as the body of the relevant chapter in this thesis, in the format 
required by the journal. 
The appendices to the thesis include summaries of other program requirements or 
achievements completed outside these four major projects. I developed public health 
communications materials for a non-scientific audience in the form of participant information 
for the NHMRC-funded Beating Buruli in Victoria case-control study. I completed three 
teaching activities; a lecture on data visualisation, a session on the basics of social network 
analysis for infectious diseases, and a “lesson from the field” on tuberculosis cluster and 
outbreak investigations. Finally, I present a short summary of my involvement as a team 
leader/epidemiologist in the Surveillance and Monitoring to Eliminate Lymphatic Filariasis and 
Scabies in Samoa (SaMELFS Samoa) mosquito survey and molecular xenomonitoring study, for 
which I travelled to Samoa in June 2019. 
Through the completion of the projects and activities recorded in this thesis, I have clearly 
demonstrated the core field epidemiology training program competencies, and accumulated 
knowledge and experience that will no doubt serve me well in the future.
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Chapter I 
Summary of Field Experience 
 
Introduction 
For the duration of the 2018-2019 Australian National University (ANU) Master of Philosophy 
(Applied Epidemiology) program (MAE) I was based at the Victorian Department of Health and 
Human Services and the Burnet Institute in Melbourne, Victoria, Australia.  
The Victorian Department of Health and Human Services (DHHS or the Department) is a state 
government department responsible for a broad range of public services including public 
health, public hospitals, ambulance services, child safety, mental health and sports. The 
Department currently provides advice to four government ministers and directly employs over 
11,000 staff throughout Victoria. 
My placement at the Department was with the Communicable Disease Epidemiology and 
Surveillance unit (CDES) in the Health Protection branch, based at 50 Lonsdale Street, 
Melbourne. Managed by Dr Nicola Stephens (up until February 2019, thereafter by MAE 
alumnus Lucinda Franklin), CDES is responsible for the collection and analysis of communicable 
disease surveillance data in Victoria, primarily through the operation of a notifiable disease 
surveillance system.  
CDES works closely with other units in the Communicable Disease section (including 
Communicable Disease Investigation and Response and Immunisation) in the collection, 
interpretation and use of surveillance data for public health action. Epidemiologists from the 
section also increasingly provide support for non-communicable disease epidemiology 
throughout the branch including elevated blood lead, epidemic thunderstorm asthma, heat 
health and anaphylaxis. 
Dr Ee Laine Tay was my primary field supervisor at DHHS. Ee Laine is a medically-trained 
epidemiologist and completed the MAE in 2012-13 through a joint placement at the 
Department and the Victorian Infectious Diseases Reference Laboratory (VIDRL). Ee Laine is 
primarily responsible for the surveillance of the notifiable mycobacterial diseases; tuberculosis, 
Buruli ulcer and leprosy. 
The Burnet Institute (Burnet or the Institute) is an independent, not-for-profit medical 
research organisation that aims to link laboratory and field-based medical research to practical 
public health action both in Australia and overseas. Headquartered at 85 Commercial Road, 
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Melbourne, the institute also maintains international offices in China, Laos PDR, Myanmar, 
Papua New Guinea and Zimbabwe. 
My placement at the Burnet Institute was with the Surveillance and Evaluation group, which 
operates under the Disease Elimination program and the Public Health discipline. The 
objectives of the group are: 
• Managing, developing and refining innovative surveillance systems to better 
understand the transmission of HIV, blood borne viruses (BBVs) including hepatitis B 
and C and sexually transmissible infections (STIs). 
• Undertaking evaluation projects to examine the effectiveness of policy and initiatives 
aimed at reducing the transmission and impact of communicable diseases, including 
BBVs and STIs. 
• Integrating findings from surveillance, epidemiology and research to inform policy and 
practice to prevent the transmission of diseases such as HIV and other STI 
transmission. 
My primary field supervisor at the Burnet Institute was Carol El-Hayek, Head of Surveillance 
and Evaluation. Carol is an experienced epidemiologist with a strong background in HIV, BBV 
and STI epidemiology, and an Adjunct Research Fellow with Monash University’s School of 
Population Health & Preventive Medicine. 
Core Applied Epidemiology Competencies 
As a field epidemiology training program (FETP), the MAE program focuses on the 
development and demonstration of the core competencies expected of a field epidemiologist.  
The demonstration of these competencies during my candidature, and their documentation in 
this thesis, is summarised below. 
Core competency 
Chapter 
II 
Chapter 
III 
Chapter 
IV 
Chapter 
V 
Appendices 
Investigate an acute public health problem      
Analyse a public health dataset      
Evaluate a surveillance system      
Design & conduct an epidemiological study      
Conduct a targeted literature review      
Communication to a non-scientific audience      
Publication in a peer-reviewed journal   *   
Oral presentation at a scientific conference      
* A manuscript based on this project has been submitted for review to the peer-reviewed journal Sexual Health. 
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Additional Applied Epidemiology Activities 
During the MAE program I had the opportunity to be involved in a range of activities outside 
those required meet the core competencies of the program. Some of these activities included:  
• For the second quarter of 2018 I coordinated Victorian HIV surveillance data at the 
Burnet Institute on behalf of DHHS, including data analysis for and production of the 
quarterly Victorian HIV surveillance report, and the reporting of jurisdictional 
surveillance data to the Kirby Institute for inclusion in national HIV surveillance and 
reporting. 
• During 2019 I contributed to the management and analysis of gonorrhoea and 
chlamydia data extracted from the Burnet Institute’s sentinel surveillance system, to 
produce the 2019 Victorian ACCESS Report. This report is provided by the Burnet 
Institute to the Victorian Department of Health and Human Services on an annual 
basis. 
• Throughout 2018-2019 I was involved in the surveillance of notifiable mycobacterial 
diseases (tuberculosis, Buruli ulcer and leprosy) at DHHS. This involved reviewing 
notifications of these diseases to assign them for follow-up by Public Health Officers or 
the Victorian Tuberculosis Program as required. I also presented a mycobacterial 
diseases surveillance report at the weekly CDES surveillance meeting. 
• As part of the third MAE courseblock in early 2019 I was invited to present a lecture to 
my fellow MAE scholars on the basics of social network analysis. This additional 
teaching activity is presented as part of Appendix B. I was also invited by Deakin 
University to be a panel member for “Careers in Epidemiology and Environmental 
Health” at a careers workshop for final-year undergraduate biomedical science 
students. 
• In June 2019 I travelled to Samoa as part of the SaMELFS Samoa study, where I worked 
as a team leader/epidemiologist for an entomology/molecular xenomonitoring survey. 
My duties as part of this study included: 
▪ Managing a field team consisting of two Australian entomologists and three 
Samoa Red Cross workers.  
▪ Managing and reconciling project fieldwork budgets, organising village visits, 
mosquito trap deployment and collection, and other logistical considerations 
and challenges associated with operating a project in a field setting. 
▪ Coordinating the collection, management and reporting of survey data using a 
cloud-based electronic data system and RStudio scripts. 
My involvement in this study is further detailed in Appendix C.  
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Chapter III 
Delays in Patient Presentation and Diagnosis for Buruli Ulcer 
(Mycobacterium ulcerans Infection) in Victoria, Australia, 2011–
2017 
Abstract 
Uncertainty regarding transmission pathways and control measures makes prompt 
presentation and diagnosis for Buruli ulcer critical. To examine presentation and diagnosis 
delays in Victoria, Australia, we conducted a retrospective study of 703 cases notified between 
2011 and 2017, classified as residing in an endemic (Mornington Peninsula; Bellarine 
Peninsula; South-east Bayside and Frankston) or non-endemic areas. Overall median 
presentation delay was 30 days (IQR 14–60 days), with no significant change over the study 
period (P=0.11). There were significant differences in median presentation delay between 
areas of residence (P=0.02), but no significant change over the study period within any area. 
Overall median diagnosis delay was 10 days (IQR 0–40 days), with no significant change over 
the study period (P=0.13). There were significant differences in median diagnosis delay 
between areas (P<0.001), but a significant decrease over time only on the Mornington 
Peninsula (P<0.001). On multivariable analysis, being aged <15 or >65 years; having non-
ulcerative disease; and residing in the Bellarine Peninsula or South-East Bayside (compared to 
non-endemic areas) were significantly associated with shorter presentation delay. Residing in 
the Bellarine or Mornington Peninsula and being notified later in the study period were 
significantly associated with shorter diagnosis delay. To reduce presentation and diagnosis 
delays, awareness of Buruli ulcer must be raised with the public and medical professionals, 
particularly those based outside established endemic areas. 
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Background 
The concept for this project originated before I started the MAE program, through my 
involvement with Buruli ulcer surveillance as a Public Health Officer in the Victorian 
Department of Health and Human Services’ Communicable Disease Investigation and Response 
unit. Commencing the MAE allowed me access to the time and surveillance data needed to 
thoroughly examine delays in presentation and diagnosis for Buruli ulcer in Victoria. 
To complete this project, I developed the methodology with the support of Ee Laine Tay, 
obtained ethics approval from the ANU HREC, completed data cleaning and analysis on the 
surveillance dataset, prepared the draft manuscript and coordinated the process of supervisor, 
co-author and peer review through to the final publication in Tropical Medicine and Infectious 
Disease, the official journal of the Australian College of Tropical Medicine. 
Lessons 
This project was the first time that I had completed an application for ethics approval through 
a university human research ethics committee. Although this project was considered low risk, 
it underscored the importance of considering the ethical foundation of any epidemiological 
research using health data. 
As my first significant experience with analysing rather than collecting surveillance data, I 
quickly learned that surveillance datasets are rarely complete or ready for analysis straight 
“out of the system”. Missing or inconsistent historical data comes with the territory. This 
emphasised the importance of thorough, consistent data collection at all points of the 
surveillance process. The amount of an epidemiologist’s time that goes into cleaning and 
preparing data before undertaking any analysis is something that many data consumers and 
end-users do not fully appreciate.  
This project also served as a great learning opportunity to improve my skills with the Stata 
software package, which were at a functional but basic level at the start of the MAE. Likewise, 
the survival analysis methodology used to examine delays in presentation and diagnosis was 
new to me and allowed me to deepen my understanding of both the statistical tests involved 
in conducting a survival analysis, and how to organise data and perform these tests using 
Stata. 
Impact 
The results of this project can be used by DHHS to target public health messaging regarding 
Buruli ulcer to medical practitioners in areas where lengthy delays in diagnosis remain. I hope 
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the findings regarding the lack of a decrease in presentation delays across the state will 
prompt a review of how the department communicates the risk of Buruli ulcer to the general 
public, and the importance of prompt presentation and diagnosis to minimise the severity and 
impact of the disease.  
This study was published in the peer-reviewed journal Tropical Medicine and Infectious Disease 
in July 2019 – the final published manuscript forms the main body of this chapter. I also 
presented the results of the study at the ANU National Centre for Epidemiology and 
Population Health Seminar Series in February 2019. The slides for this presentation are 
included at the end of this chapter. 
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Chapter IV 
The epidemiology and subtype diversity of HIV-1 in the newly-
arrived Asian-born MSM population in Victoria, Australia 2015-
2018: An observational study based on routinely collected 
surveillance data 
 
Abstract 
We used routinely collected surveillance data to improve our understanding of locally-acquired 
HIV transmission and sexual mixing within and between the newly-arrived Asian-born and 
Australian-born men who have sex with men (MSM) populations.  
The study population included 444 newly-diagnosed HIV cases notified between 1 January 
2015 – 31 December 2018 with subtyping data available. 84% were classified as locally-
acquired and 16% as overseas-acquired. 
Epidemiological data collected from diagnosing medical practitioners were linked to subtyping 
data from the state reference laboratory. Populations were characterised using frequencies, 
percentages, medians and interquartile ranges. Comparisons between populations were made 
were using the chi-squared, Fisher’s exact, or Mann-Whitney U test. Exact binomial confidence 
intervals were calculated for proportions. 
Of the locally-acquired cases, were 267 Australian-born and 104 newly-arrived Asian born. 
Thirteen HIV-1 forms were observed including four pure subtypes (n=271, 73%), five circulating 
(n=94, 25%) and four unique recombinant forms (n=6, 2%). Most infections were subtype B 
(212/267, 79%) in Australian-born and non-B (62/104, 60%) in newly-arrived Asian-born MSM. 
Newly-arrived Asian-born cases were younger (median age 29 vs 32 years, P=0.02) and had a 
lower median CD4+ cell count at diagnosis (365 vs 449 cells/μL, P=0.009). In Asian-born cases, 
subtype B accounted for a larger proportion of locally-acquired infections compared to the 
overseas-acquired infections (40% vs 29%, p=0.21) 
These findings provide important biological data to support the theory that local transmission 
in both populations is mostly assortative based on ethnicity. However, the 40% of Asian-born 
MSM infected with subtype B and 21% of Australian-born with non-B subtypes may be 
suggestive of sexual mixing and local transmission between the two populations. We must 
better understand the prevention, testing and treatment needs of the growing newly-arrived 
Asian-born MSM population and address them in a culturally appropriate manner.  
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Background 
The concept for this project was originally conceived by Professor Margaret Hellard at the 
Burnet Institute. We had initially hoped to use HIV-1 whole genome sequencing data to 
identify transmission clusters and examine transmission within and between the Australian-
born and newly-arrived Asian-born MSM populations. However, due to constraints at the 
public health laboratory over the period in which I needed to complete the project, we were 
unable to do so. We therefore made the decision to continue with the project using readily 
available and routinely collected subtyping and epidemiological surveillance data. 
To complete this project, I developed the project proposal and data analysis plan, obtained 
ethics approval from the ANU HREC, submitted a data request to DHHS to obtain the linked 
surveillance and subtyping data, cleaned and analysed the data, interpreted and presented the 
results of analyses and prepared the manuscript. 
Feedback and guidance were provided by my placement and academic supervisors 
(particularly Carol El-Hayek) throughout the project, as well as from other co-authors on the 
manuscript developed for publication.   
Lessons 
This study once again underscored the importance of good data collection processes at all 
points in a passive surveillance system; from the notifying doctor, the public health officer, the 
epidemiologist and the design of the surveillance system itself. Missing or inconsistent data 
fields (e.g. place of birth, year of arrival in Australia or exposure risk) that could have been 
easily rectified at the time of notification can mean the exclusion of many cases from a 
retrospective study. 
It also served to illustrate, despite the above-mentioned limitations, how routinely collected 
epidemiological and laboratory surveillance data can be retrospectively analysed together to 
characterise emerging at-risk populations and provide a starting point and impetus for further 
research. 
Finally, I came to appreciate the benefits of whole genome sequencing over subtyping for 
exploring and inferring HIV transmission clusters. The superior resolution provided by whole 
genome sequencing could provide a far more detailed picture of HIV transmission within and 
between risk populations, allowing for a more thorough exploration of transmission patterns 
and the targeting of interventions. I have no doubt that this research will be done to further 
characterise HIV transmission in at-risk population in Victoria in the coming years.  
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Impact 
Understanding and addressing HIV transmission in the newly-arrived Asian-born MSM 
population is increasingly important in Victoria, with both the population and the proportion 
of HIV notifications from the population increasing in recent years. I hope that this study, along 
with those cited in the chapter, provides an impetus for further research, evidence-based 
public health policy and effective services and interventions to reduce the incidence of HIV in 
this population. 
The results of this study were presented as an invited oral presentation at the International 
Union Against Sexual Transmitted Infections (IUSTI) Asia-Pacific Conference in Shanghai, China 
in October 2019. The slides for this presentation are included at the end of the chapter.  
A manuscript based on this project has been submitted for review to the peer-reviewed 
journal Sexual Health. Published by the CSIRO, Sexual Health is the official journal of the IUSTI 
Asia-Pacific region. 
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Abstract 
Background  
We used routinely collected surveillance data to improve our understanding of locally-acquired 
HIV transmission and sexual mixing within and between the newly-arrived Asian-born and 
Australian-born men who have sex with men (MSM) populations.  
Methods  
The study population included 444 newly-diagnosed HIV cases notified between 1 January 
2015 – 31 December 2018 with subtyping data available. 84% were classified as locally-
acquired and 16% as overseas-acquired. 
Epidemiological data collected from diagnosing medical practitioners were linked to subtyping 
data from the state reference laboratory. Populations were characterised using frequencies, 
percentages, medians and interquartile ranges. Comparisons between populations were made 
were using the chi-squared, Fisher’s exact, or Mann-Whitney U test. Exact binomial confidence 
intervals were calculated for proportions. 
Results  
Of the locally-acquired cases, were 267 Australian-born and 104 newly-arrived Asian born. 
Thirteen HIV-1 forms were observed including four pure subtypes (n=271, 73%), five circulating 
(n=94, 25%) and four unique recombinant forms (n=6, 2%). Most infections were subtype B 
(212/267, 79%) in Australian-born and non-B (62/104, 60%) in newly-arrived Asian-born MSM. 
Newly-arrived Asian-born cases were younger (median age 29 vs 32 years, P=0.02) and had a 
lower median CD4+ cell count at diagnosis (365 vs 449 cells/μL, P=0.009). In Asian-born cases, 
subtype B accounted for a larger proportion of locally-acquired infections compared to the 
overseas-acquired infections (40% vs 29%, p=0.21) 
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Discussion 
These findings provide important biological data to support the theory that local transmission 
in both populations is mostly assortative based on ethnicity. However, the 40% of Asian-born 
MSM infected with subtype B and 21% of Australian-born with non-B subtypes may be 
suggestive of sexual mixing and local transmission between the two populations. We must 
better understand the prevention, testing and treatment needs of the growing newly-arrived 
Asian-born MSM population and address them in a culturally appropriate manner.  
Background 
In the state of Victoria, Australia the number of newly-diagnosed HIV cases notified to the 
Department of Health and Human Services (DHHS) among men who have sex with men (MSM) 
has decreased from 234 cases in 2016 to 155 in 2018.1 This decline was likely a result of the 
increasingly widespread availability of HIV testing, pre-exposure prophylaxis (PrEP) and 
antiretroviral treatment as prevention, all of which are supported by state and national HIV 
strategies.2-4 Recent surveillance and research attributes the majority of the decline to a 
reduction in diagnoses in Australian-born MSM. In contrast, the proportion of total incident 
cases from the newly-arrived Asian-born MSM population has been increasing.1, 5, 6 One study 
based in Melbourne, Victoria found newly-arrived Asian-born MSM were more than four times 
more likely to be diagnosed with incident HIV than Australian-born MSM by the end of the 
five-year study period in 2017. 6 The comparatively young median age and newly-arrived status 
of Asian-born MSM in this study (26.4 years, interquartile range 23.5 - 29.8) suggests that the 
population may be primarily international students.  
Victoria has a growing temporary resident population of international students originating 
from Asian nations. In 2018, over 200,000 international students enrolled in post-secondary 
educational institutions in Victoria; nine of the top ten countries of origin for these students 
were located in Asia.7 Among newly-arrived Asian-born MSM, especially those on time-limited 
student visas, increasing HIV diagnoses may be due in part to: a lack of access to Australian 
government-funded medical (Medicare) and pharmaceutical (Pharmaceutical Benefits Scheme 
(PBS)) preventative health services such as HIV testing, pre-exposure prophylaxis (PrEP) and 
antiretroviral therapy (ART);8 poorer knowledge of sexual health and risk reduction strategies;9 
stigmatisation and/or criminalisation of male-to-male sexual activity in their home country;10 
and lower levels of identification with and connection to the local gay community and 
culture.11 Previous research, based on self-reported patient data, has suggested there may be 
significant assortative sexual mixing among Asian-born MSM in Victoria.6 As a result of 
assortative sexual mixing by ethnicity, and the potentially higher prevalence of undiagnosed 
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and/or untreated HIV within this population, newly-arrived Asian-born MSM may also be at 
higher risk of sexual contact with a partner who is infectious for HIV.12   
HIV subtyping data can provide an indication of the likely geographic origin of infections, and 
of transmission between populations.13 The HIV-1 group M virus is responsible for the vast 
majority of HIV infections worldwide.14 It is currently classified into nine subtypes (A–D, F–H, J 
and K), six sub-subtypes (A1–A4, F1 and F2) and an increasing number of circulating and 
unique recombinant forms (CRFs and URFs). This subtype diversity has primarily evolved due 
to the rapid generation and reverse transcriptase error rate of the virus.15 Recombinant forms 
can arise when multiple viruses of differing subtypes infecting an individual simultaneously 
recombine – they may later be recognised as CRFs based on ongoing transmission.16 The 
clinical significance of these different subtypes remains unclear, though there is some evidence 
that disease progression and CD4 count recovery after the commencement of treatment may 
differ between subtypes.17, 18 As HIV-1  has spread globally, differences in epidemic timing and 
population characteristics, structure and movements have resulted in the divergence of 
subtype diversity and predominant subtypes between geographical areas.19 Previous research 
indicates the majority of incident HIV cases in the Australian-born MSM population are of the 
HIV-1 B subtype, which is also predominant throughout North America and Europe.20, 21 With 
the exception of Japan and South Korea,22, 23 non-B subtypes and CRFs predominate 
throughout Asia, with the diversity and predominant strains varying country-to-country.24  
It could be expected that if there was sexual mixing and local transmission between the newly-
arrived Asian-born MSM (from countries where non-B subtypes predominate) and Australian-
born MSM populations (where subtype B predominates), a significant proportion of infections 
in newly-arrived Asian-born MSM would be subtype B, and a significant proportion of 
infections in Australian-born MSM would be non-B subtypes.  
we combined routinely collected epidemiological and genotyping surveillance data to improve 
our understanding of locally-acquired HIV transmission and sexual mixing within and between 
the newly-arrived Asian-born and Australian-born MSM populations.  
Methods 
Data sources 
The Victorian Department of Health and Human Services (DHHS) routinely collects HIV 
surveillance data from diagnosing medical practitioners through a statutory notification 
process.25 Surveillance data are submitted by medical practitioners to DHHS using a 
standardised HIV notification form and recorded electronically on the Public Health Event 
Surveillance System (PHESS) database. The enhanced surveillance form collects data on case 
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demographics, clinical characteristics and HIV testing, risk and exposure history. These data are 
generally based on self-reported information provided to the clinician by the case. Data 
completeness for the surveillance forms varies, however DHHS public health officers 
undertake follow-up with notifying medical practitioners if key data fields are not completed.  
Partial sequencing of the HIV pol gene and subtyping analysis was performed at the Victorian 
Infectious Diseases Reference Laboratory (VIDRL). Sequencing is done at the request of the 
treating medical practitioner, resulting in subtyping data being available for only a subset of 
notified cases in Victoria during the study period. In collaboration with VIDRL, subtyping data 
for each case are matched to the DHHS routinely-collected HIV surveillance data using a 
unique identification number generated in PHESS. For cases with multiple sequences in the 
subtyping dataset (primarily due to repeated testing for drug resistance purposes), the earliest 
available sequence was used for this study. 
Definitions 
The following definitions were used to define the study population, based on risk and exposure 
data fields routinely collected by DHHS for HIV surveillance. 
• Australian-born – country of birth recorded as Australia. 
• Asian-born – country of birth recorded as one of the 53 sovereign states in Asia. 
• Locally-acquired – likely place of acquisition recorded as Australia. 
• Overseas-acquired – likely place of acquisition recorded as a country other than 
Australia. 
• Newly-arrived – year of arrival in Australia recorded as ≤ 4 years before first recorded 
HIV diagnosis. This cut-off aimed to capture most Asian-born international students on 
time-limited student immigration visas (a key population of interest in this setting) 
whilst excluding individuals who have lived in-country for extended periods of time. 
• MSM – at least one risk for exposure to HIV recorded as male-to-male sexual contact. 
Individuals who identified as transgender and reported sex with MSM were included. 
Study population 
The study population included all newly-diagnosed HIV cases notified to DHHS during the study 
period (1 January 2015 – 31 December 2018) who were classified as Australian-born or newly-
arrived Asian-born MSM, and had HIV subtyping data available.  
The study population was also stratified by place of acquisition (locally-acquired vs overseas-
acquired) to compare differences in subtype acquisition. 
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Cases in the surveillance dataset for whom these criteria could not be established due to 
missing or incomplete data were excluded from the study population.  
Data analysis 
The study population was characterised through a descriptive analysis using frequencies and 
percentages, and medians and interquartile ranges (IQR) as appropriate.  
To compare the two groups of interest within the study population relevant variables from the 
surveillance dataset were analysed using chi-squared or Fisher’s exact test as appropriate 
(categorical variables) or the Mann-Whitney U test (continuous variables). Exact binomial 
confidence intervals were calculated for proportions. P values <0.05 considered statistically 
significant. Due to the low number of cases for certain variables, some data fields collected in 
the surveillance dataset were combined for the purposes of analysis where appropriate to do 
so.  
Ethics 
Ethics approval was granted by the Australian National University Human Research Ethics 
Committee on 7 January 2019 (2018/799). Individual patient consent was not required or 
sought as all data were collected under the Public Health and Wellbeing Act 2008.25 
Results 
A total of 444 HIV cases notified between 1 January 2015 – 31 December 2018 were included 
in the study population. Of these cases 84% (371/444) were classified as locally-acquired and 
16% (73/444) as overseas-acquired. 
Clinical and epidemiological characteristics of locally-acquired cases 
Of the locally-acquired cases, 267 (72%) were classified as Australian-born MSM and 104 (28%) 
as newly-arrived Asian-born MSM. There was a small increase in the proportion of newly-
arrived Asian-born cases in the study population over the study period, from 26% in 2015 to 
30% in 2018 (P=0.61). 
Newly-arrived Asian-born cases were younger at diagnosis than Australian-born cases (median 
age 29 years vs 32 years, P=0.02), more frequently reported speaking a language other than 
English at home (39% vs 5%, P<0.001), more often resided in inner-Melbourne (46% vs 34%) 
and less often in regional Victoria (1% vs 14%, P<0.001).  
Compared to Australian-born cases, newly-arrived Asian-born cases had a lower median CD4+ 
cell count at the time of diagnosis (365 vs 449 cells/μL, P=0.009). A greater proportion of 
newly-arrived Asian-born cases reported screening for STIs as their reason for testing (55% 
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versus 38%) and a lesser proportion reported screening for PrEP prescription (0% vs 2%). The 
characteristics of the study population are detailed in Table 1.  
Table 3. Characteristics of cases in the Australian-born (n=267) and newly-arrived Asian-born 
(n=104) MSM populations with newly-diagnosed, locally-acquired HIV infections over the study 
period 2015-2018. 
 
* Based on local government area at time of diagnosis: 
Inner Melbourne - Yarra, Stonnington, Melbourne, Port Phillip 
Middle Melbourne - Banyule, Bayside, Boroondara, Darebin, Glen Eira, Hobsons Bay, Kingston, Manningham, 
Maribyrnong, Monash, Moonee Valley, Moreland, Whitehorse 
Outer Melbourne - Brimbank, Frankston, Greater Dandenong, Knox, Maroondah, Mornington Peninsula, Nillumbik, 
Yarra Ranges, Cardinia, Casey, Hume, Melton, Whittlesea, Wyndham 
Regional Victoria – all other non-metropolitan local government areas 
Subtype characteristics of locally-acquired cases 
A total of 13 distinct HIV-1 subtypes, CRFs and URFs were observed in the study population 
including four pure subtypes (n=271, 73%), five CRFs (n=94, 25%) and four URFs (n=6, 2%).  
Among the nine subtypes, CRFs and URFs observed in Australian-born cases over the study 
period, subtype B predominated (n=212, 79%) followed by CRF01_AE (n=32, 12%), subtype C 
(n=11, 4%), CRF02_AG (n=3, 1%), subtype A1 (n=2, <1%) and URFs B/CRF57_BC, B/CRF01_AE 
and 07_BC/C/57_BC (each n=1, <1%).  Of the nine subtypes, CRFs and URFs  observed in newly-
arrived Asian-born cases, subtype CRF01_AE was the most common (n=49, 47%) followed by 
subtype B (n=42, 40%), CRF07_BC (n=5, 5%), subtype C (n=3, 3%), subtype G (n=1, <1%), CRFs 
P value
n % 95% CI n % 95% CI
Age (years) - Median (IQR) 32 26-42 - 29 25-35.5 - 0.02
Area of Residence * 0.002
Inner Melbourne 87 34% 28-40% 44 46% 36-56%
Middle Melbourne 73 29% 23-34% 30 31% 22-42%
Outer Melbourne 59 23% 18-29% 21 22% 14-31%
Regional Victoria 37 14% 10-19% 1 1% 0-6%
Language Spoken at Home <.001
English 211 95% 91-98% 57 61% 51-71%
Other 11 5% 2-9% 36 39% 29-49%
Reason for Testing 0.18
Screening for STIs 102 39% 33-45% 56 55% 45-65%
Investigation of symptoms suggestive of HIV 41 16% 11-20% 11 11% 6-18%
Partner with HIV 16 6% 4-10% 5 5% 2-11%
Reported recent risk behaviour 31 12% 8-16% 6 6% 2-12%
Confirmation of HIV positive status 6 2% 1-5% 2 2% 0-7%
PrEP screening 5 2% 1-4% 0 0% 0-4%
Immigration screening 1 0.4% 0-2% 1 1% 0-5%
Other 14 5% 3-9% 6 6% 2-12%
Multiple reasons 48 18% 14-23% 15 15% 8-23%
CD4+ Cell Count at Diagnosis (cells/μL) - Median (IQR) 449 312-654 - 365 270-490 - 0.009
HIV-1 Subtype <.001
Non-B subtype 55 21% 16-26% 62 60% 50-69%
B-subtype 212 79% 74-84% 42 40% 31-50%
Clinical Status at Diagnosis 0.48
Asymptomatic for HIV 192 90% 85-93% 80 87% 78-93%
Symptomatic for HIV 22 10% 7-15% 12 13% 7-22%
HIV seroconversion illness in 12 months prior 0.84
Yes 61 28% 22-35% 23 27% 18-38%
No 155 72% 65-78% 62 73% 62-82%
Aus-born Asian-born
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CRF12_BF, CRF33_01B (both n=1, <1%) and URFs B/F1 and 07_BC/C/57_BC (both n=1, <1%). A 
summary of the major subtypes, CRFs and URFs in each population over the study period is 
presented in Figure 1.  
 
Figure 1. HIV-1 subtypes observed in cases in the Australian-born (n=267) and newly-arrived 
Asian-born (n=104) MSM populations with newly-diagnosed, locally-acquired HIV infections 
over the study period 2015-2018. Subtypes with two or more cases over the study period are 
shown individually. "Other" comprises six distinct forms that occurred only once in the study 
period. 
Subtype diversity declined slightly over the study period; nine distinct forms were observed in 
2015, eight in 2016, and five in each of 2017 and 2018. There was no significant change in the 
proportion of B and non-B subtypes in either the Australian-born (P=0.76) or newly-arrived 
Asian-born (P=0.66) populations over the study period.  
Newly-arrived Asian-born cases were more frequently infected with a non-B subtype than 
Australian-born cases (60% versus 21%, P<0.001). Of the newly-arrived Asian-born cases, 40% 
(n=42) were infected with subtype B, the most common subtype in Australian-born cases. 
Among Australian born cases 21% (n=55) were infected with a non-B subtype. CRF01_AE was 
the most common non-B subtype in the Australian-born population and was the most common 
subtype in newly-arrived Asian-born cases.  
Characteristics of overseas-acquired cases 
Of the overseas-acquired cases, 52% (38/73) were Australian-born and 48% (35/73) were 
newly-arrived Asian-born MSM. 
Among Australian-born cases, non-B subtypes accounted for a larger proportion of overseas-
acquired infections compared to locally-acquired infections (58% vs 21%, P=<.001). The most 
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common overseas-acquired non-B subtype in Australian-born MSM was CRF01_AE (14/22, 
64%).  
Among the Asian-born cases, subtype B accounted for a larger proportion of locally-acquired 
infections compared to the overseas-acquired infections (40% vs 29%, p=0.21). The most 
common overseas-acquired subtype in newly-arrived Asian-born MSM was CRF01_AE (17/35, 
49%) (Figure 2). 
 
Figure 2. Proportions of HIV-1 B and non-B subtypes in the Australian-born and newly-arrived 
Asian-born MSM populations over the study period 2015-2018, by place of acquisition. 
Discussion 
This study found the majority of locally-acquired HIV infections were subtype B (79%) in 
Australian-born and non-B (60%) in newly-arrived Asian-born MSM. These findings provide 
important biological data to support the theory, previously based on self-reported patient 
data, that local transmission in both populations is mostly assortative based on ethnicity.  
However, the 40% of Asian-born MSM infected with subtype B and 21% of Australian-born 
infected with non-B subtypes may be suggestive of sexual mixing and local transmission 
between the two populations. This hypothesis is further supported by the greater proportion 
of subtype B infections acquired by newly-arrived Asian-born MSM in Australia, compared to 
infections acquired overseas. While assortative sexual mixing based on ethnicity is common, 
especially in newly-arrived communities, it is not surprising that sexual mixing occurs between 
men from these populations in the context of a large, multicultural, metropolitan city. 
These observations are important to the control of HIV in Victoria, as many newly-arrived 
Asian-born MSM do not have access to publicly funded sexual health services, have low sexual 
health and risk reduction knowledge, come from cultures where male to male sex is 
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significantly stigmatised or criminalised, and do not identify with or connect into the local gay 
community and its associated resources and collective knowledge.11 
This study also identified several significant differences in HIV epidemiology between the two 
populations including area of residence within Victoria, language other than English spoken at 
home and median CD4+ cell count at diagnosis. These findings are broadly consistent with a 
recent clinic-based study of similar populations in Victoria and New South Wales, and a 
previous Australian study that identified culturally and linguistically diverse HIV cases were 
significantly less likely to have started ART within six months of diagnosis, irrespective of their 
CD4 cell count.8, 26  
A small majority of newly-arrived Asian-born MSM in this study lived in middle to outer 
suburbs of Melbourne, while Victoria’s only sexual health service that does not require access 
to the publicly funded Medicare system is in inner-city Melbourne. This could mean there are 
individuals living with undiagnosed HIV in areas of Melbourne not well-serviced by a free-to-
access sexual health service. Further research may be required to assess the level of access to 
culturally appropriate HIV services in middle, outer and regional areas where many newly-
arrived Asian-born MSM live, work or study. This could include educational institutions with 
large Asian-born student populations in the middle to outer suburbs and regional centres. 
There were several limitations to this study. The retrospective use of routine surveillance data 
means that the veracity of the case data (such as the likely place of acquisition and sexual 
exposures) could not be verified. Although the data is suggestive of sexual mixing and 
transmission between populations, the small sample size and resulting small numbers of cases 
within subgroups and the relatively short four-year study period made it difficult to draw firm 
conclusions on trends in transmission. The use of HIV subtyping analysis alone to make 
inferences on transmission is also relatively limited - in the future, routine genomic sequencing 
of all HIV isolates would be useful to facilitate detailed, high-resolution studies combining 
epidemiological and phylogenetic surveillance data. Such studies would better elucidate local 
transmission dynamics within Victoria’s MSM populations. 
Victoria has made strong progress toward the elimination of HIV. If this is to continue, public 
health authorities and the research community must better understand the prevention, testing 
and treatment needs of the growing newly-arrived Asian-born MSM population and address 
them in a culturally appropriate manner.  
59 
` 
 
References 
1. Victorian Department of Health and Human Services. HIV quarterly surveillance report: 
January-March 2019. Melbourne, Victoria2019. 
2. Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia: 
Annual surveillance report 2018. Sydney: UNSW, 2018. 
3. Australian Government Department of Health. Eighth National HIV Strategy 2018-
2022. Canberra, Australian Capital Territory2018. 
4. Victorian Department of Health and Human Services. Victorian HIV strategy 2017-
2020. Melbourne, Victoria2017. 
5. Gunaratnam P, Heywood AE, McGregor S, et al. HIV diagnoses in migrant populations 
in Australia-A changing epidemiology. PLoS One. 2019;14(2):e0212268. 
6. Medland NA, Chow EPF, Read THR, et al. Incident HIV infection has fallen rapidly in 
men who have sex with men in Melbourne, Australia (2013-2017) but not in the newly-arrived 
Asian-born. BMC Infect Dis. 2018;18(1):410. 
7. Australian Government Department of Education and Training. International Student 
Data 2018 2018. Available from: https://internationaleducation.gov.au/research/international-
student-data/pages/default.aspx. 
8. Blackshaw LCD, Chow EPF, Varma R, et al. Characteristics of recently arrived Asian men 
who have sex with men diagnosed with HIV through sexual health services in Melbourne and 
Sydney. Aust N Z J Public Health. 2019. 
9. Song A, Richters J, Crawford J, et al. HIV and sexual health knowledge and sexual 
experience among Australian-born and overseas-born students in Sydney. Journal of 
Adolescent Health. 2005;37(3):243.e249-243.e214. 
10. Arreola S, Santos GM, Beck J, et al. Sexual stigma, criminalization, investment, and 
access to HIV services among men who have sex with men worldwide. AIDS and behavior. 
2015;19(2):227-234. 
11. Wong H, Prankumar S, Prihaswan P, et al. Notes from the field: Challenges, concerns 
and opportunities in relationship building and health promotion among gay Asian international 
students in Australia. Australian Federation of AIDS Organisations [Internet]. 2019. Available 
from: https://www.afao.org.au/wp-content/uploads/2019/08/HIV-Australia_Notes-from-the-
field-2.pdf. 
12. Chow EPF, Read TRH, Law MG, et al. Assortative sexual mixing patterns in male-female 
and male-male partnerships in Melbourne, Australia: implications for HIV and sexually 
transmissible infection transmission. Sex Health. 2016;13(5):451-456. 
13. Paraskevis D, Nikolopoulos GK, Magiorkinis G, et al. The application of HIV molecular 
epidemiology to public health. Infection, genetics and evolution : journal of molecular 
epidemiology and evolutionary genetics in infectious diseases. 2016;46:159-168. 
14. Faria NR, Rambaut A, Suchard MA, et al. HIV epidemiology. The early spread and 
epidemic ignition of HIV-1 in human populations. Science (New York, NY). 2014;346(6205):56-
61. 
15. Lai A, Bozzi G, Franzetti M, et al. Phylogenetic analysis provides evidence of 
interactions between Italian heterosexual and South American homosexual males as the main 
source of national HIV-1 subtype C epidemics. Journal of medical virology. 2014;86(5):729-736. 
16. Robertson DL, Anderson JP, Bradac JA, et al. HIV-1 nomenclature proposal. Science 
(New York, NY). 2000;288(5463):55-56. 
17. Geretti AM, Harrison L, Green H, et al. Effect of HIV-1 subtype on virologic and 
immunologic response to starting highly active antiretroviral therapy. Clinical infectious 
diseases : an official publication of the Infectious Diseases Society of America. 
2009;48(9):1296-1305. 
60 
 
18. Touloumi G, Pantazis N, Pillay D, et al. Impact of HIV-1 subtype on CD4 count at HIV 
seroconversion, rate of decline, and viral load set point in European seroconverter cohorts. 
Clin Infect Dis. 2013;56(6):888-897. 
19. Sharp PM, Hahn BH. Origins of HIV and the AIDS Pandemic. Cold Spring Harbor 
Perspectives in Medicine:. 2011;1(1):a006841. 
20. Castley A, Sawleshwarkar S, Varma R, et al. A national study of the molecular 
epidemiology of HIV-1 in Australia 2005-2012. PLoS One. 2017;12(5):e0170601. 
21. Chibo D, Birch C. Increasing diversity of Human Immunodeficiency Virus type 1 
subtypes circulating in Australia. AIDS research and human retroviruses. 2012;28(6):578-583. 
22. Kim GJ, Nam JG, Shin BG, et al. National survey of prevalent HIV strains: limited genetic 
variation of Korean HIV-1 clade B within the population of Korean men who have sex with 
men. Journal of acquired immune deficiency syndromes (1999). 2008;48(2):127-132. 
23. Takebe Y, Naito Y, Raghwani J, et al. Intercontinental dispersal of HIV-1 subtype B 
associated with transmission among men who have sex with men in Japan. Journal of virology. 
2014;88(17):9864-9876. 
24. Shao Y, Williamson C. The HIV-1 epidemic: low- to middle-income countries. Cold 
Spring Harbor perspectives in medicine. 2012;2(3):a007187-a007187. 
25. Public Health and Wellbeing Act (Victoria), (2008). 
26. Gunaratnam P, McManus H, Watchirs-Smith L, et al. People Born in Non-Main English 
Speaking Countries Are Less Likely to Start HIV Treatment Early in Australia: A National Cohort 
Analysis, 2014-15. Journal of acquired immune deficiency syndromes (1999). 2018;77(3):e31-
e34. 
 
  
61 
` 
Oral Presentation at the International Union Against Sexually 
Transmitted Infections Asia Pacific Conference - Shanghai, China 
25 October 2019 
 
 
 
 
 
62 
 
 
 
  
102 
 
Appendix 1. ACCESS Activity Performance Indicators and Required Activities – Health Surveillance Fund 2016-2019 
ACCESS - Activity Performance Indicators – Health Surveillance Fund 2016-2019 
# Activity Activity Detail Information Source(s) Performance Indicator(s) 
1 Project Establishment 
Submit a work plan and budget, recruit project staff and 
develop a project evaluation plan. 
▪ Internal documentation 
▪ Stakeholder interviews 
▪ Submitted to and accepted by the Department of 
Health. 
2 Expand the ACCESS network 
Expand ACCESS networks to all jurisdictions through the 
Laboratory Network, Sexual Health Service (SHS) 
Network and the Primary Health and High Caseload 
Service (PHHCS) Network. 
▪ Internal documentation 
▪ Stakeholder interviews 
▪ At least 1 major SHS recruited from each 
jurisdiction within the agreed timeframe. 
▪ At least 2 key clinics (PHHCS) in most jurisdictions 
but a minimum of one in all jurisdictions, within the 
agreed timeframe. 
▪ At least 4 labs recruited in each of NSW and VIC, 3 
in QLD, 1 in each of other jurisdictions (exc. TAS) 
within the agreed timeframe. 
3 
Programs and procedures in 
place for data extraction, 
review and analysis from 
each site. 
Electronically extract clinic consultation and diagnostic 
test data from existing patient management 
information systems at participating clinics, and 
BBV/STI testing data from participating laboratory sites. 
▪ Internal documentation 
▪ Stakeholder interviews 
▪ GRHANITETM successfully installed at all recruited 
sites within the agreed timeframes. 
▪ Data is extracted from all recruited sites and 
analysis completed within the agreed timeframes. 
4 
Report on test outcomes in 
priority populations 
Testing rate and proportion positive for BBVs (HIV, HBV 
and HCV) and STIs (chlamydia, gonorrhoea and syphilis) 
in gay and bisexual men, people who inject drugs, sex 
workers, the CALD populations and Aboriginal and 
young people (as relevant). 
▪ Kirby Annual Report 
▪ ACCESS data 
▪ Internal documentation 
▪ Stakeholder interviews 
▪ Key indicator data for the goals and targets outlined 
in the National BBV and STI Surveillance and 
Monitoring Plan published in 2019 Kirby annual 
report. 
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ACCESS - Other Required Activities – Health Surveillance Fund 2016-2019 
Activity Activity detail Information source(s) 
 
Ensure engagement with priority 
populations to inform the 
development of ACCESS 
 
▪ Expand engagement with relevant community organisations. 
▪ Actively seek input and feedback from priority populations. 
▪ Establish and maintain a national steering committee for ACCESS 
including representation from individuals and organisations 
relevant to each network.  
▪ Internal documentation 
▪ Stakeholder interviews 
Undertake key analyses for each 
BBV and STI, for priority 
populations 
 
Key analyses should include: 
▪ Number of consults per patient per year 
▪ Characteristics of patients tested 
▪ Completeness of screening 
▪ Testing uptake 
▪ Testing frequency 
▪ Proportion testing positive 
▪ Assessment of care cascades (HIV and HCV) 
▪ Assessment of HBV immunity 
▪ ACCESS data 
▪ Internal documentation 
▪ Stakeholder interviews 
Share results of analyses with 
stakeholders and the public  
Result should be shared via: 
▪ Annual routine reports for each network. 
▪ Site-specific reports to participating sites. 
▪ Published reports 
▪ Peer reviewed publications and 
abstracts 
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▪ Newsletters to government, community and other stakeholders. 
▪ Provision of data to key national and jurisdictional government 
reports. 
▪ Regular presentation of results and emerging trends at key forums. 
▪ Analysis and publication of key results in peer-reviewed journals. 
▪ Provision of data to governments and other interested parties for 
further analysis. 
▪ Publication of de-identified data on the ACCESS website. 
▪ Media/communications materials 
▪ ACCESS website 
▪ Stakeholder interviews 
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Appendix 2. Peer-reviewed publications using ACCESS data, 2016-2019 
2019 
Sexually transmissible infections among transgender men and women attending Australian 
sexual health clinics. Callander D, Cook T, Read P, Hellard ME, Fairley CK, Kaldor JM, Vlahakis 
E, Pollack A, Bourne C, Russell DB, Guy RJ, Donovan B Med J Aust. 2019 August; Epub ahead of 
print 
A comparative, retrospective analysis of HIV testing among gay, bisexual and other men who 
have sex with men in Melbourne, Australia. Ryan KE, Wilkinson AL, Chow E, Read T, Chen 
M, Locke P, Leitinger D, Bradshaw C, Pedrana A, Hellard M, Fairley CK, Stoové M Aust N Z J 
Public Health. 2019 May; Epub ahead of print 
Assessment of service refinement and its impact on repeat HIV testing by client's access to 
Australia's universal healthcare system: a retrospective cohort study. Ryan KE, Wilkinson 
AL, Asselin J, Leitinger DP, Locke P, Pedrana A, Hellard M, Stoové M. J Int AIDS Soc. 2019 
Aug;22(8):e25353 
Association of HIV Preexposure Prophylaxis with Incidence of Sexually Transmitted 
Infections Among Individuals at High Risk of HIV Infection. Traeger MW, Cornelisse VJ, Asselin 
J, Price B, Roth NJ, Willcox J, Tee BK, Fairley CK, Chang CC, Armishaw J, Vujovic O, Penn M, 
Cundill P, Forgan-Smith G, Gall J, Pickett C, Lal L, Mak A, Spelman TD, Nguyen L, Murphy DA, 
Ryan KE, El-Hayek C, West M, Ruth S, Batrouney C, Lockwood JT, Hoy JF, Hellard ME, Stoové 
MA, Wright EJ; PrEPX Study Team JAMA. 2019 Apr; 321(14):1380-1390 
Gonorrhoea gone wild: rising incidence of gonorrhoea and associated risk factors among gay 
and bisexual men attending Australian sexual health clinics. Callander D, Guy R, Fairley CK, 
McManus H, Prestage G, Chow EPF, Chen M, Connor CCO, Grulich AE, Bourne C, Hellard M, 
Stoové M, Donovan B Sex Health. 2019 Jan; Epub ahead of print 
Early initiation of antiretroviral therapy for people newly diagnosed with HIV infection in 
Australia: trends and predictors, 2004-2015. McManus H, Callander D, Donovan B, Russell DB, 
O'Connor CC, Davies SC, Lewis DA, Hellard ME, Chen MY, Petoumenos K, Varma R, Cogle A, 
Boyd MA, Grulich A, Pollard J, Medland N, Fairley CK, Guy RJ Med J Aust. 2019 Feb; 210(6):269-
275 
Can Australia reach the World Health Organization Hepatitis C elimination goal by 2025 
among HIV-positive gay and bisexual men? Boettiger DC, Salazar-Vizcaya L, Dore GJ, Gray RT, 
Law MG, Callander D, Lea T, Rauch A, Matthews GV, 2019, Clin Infect Dis, 
http://dx.doi.org/10.1093/cid/ciz164 
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2018 
Monitoring the Control of Sexually Transmissible Infections and Blood-Borne Viruses: 
Protocol for the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance 
(ACCESS). Callander D, Moreira C, El-Hayek C, Asselin J, van Gemert C, Watchirs Smith L, 
Nguyen L, Dimech W, Boyle DI, Donovan B, Stoové M, Hellard M, Guy R JMIR Res Protoc. 2018 
Nov; 7(11): e11028 
Assessing the Impacts of Integrated Decision Support Software on Sexual Orientation 
Recording, Comprehensive Sexual Health Testing, and Detection of Infections Among Gay 
and Bisexual Men Attending General Practice: Observational Study. Callander D, Bourne C, 
Wand H, Stoové M, Hocking JS, de Wit J, Kaldor JM, Donovan B, Pell C, Finlayson R, Baker D, 
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Appendix A 
Communication to a Non-Scientific Audience 
 
This appendix contains three participant information documents that I prepared for Barwon 
Health to use in the case-control study component of the NHMRC Partnership Project funded 
Beating Buruli in Victoria project.  
The Beating Buruli in Victoria project is a two-year collaborative research partnership between 
the Victorian Department of Health and Human Services, the Doherty Institute, Barwon 
Health, Austin Health, CSIRO, Agriculture Victoria, the University of Melbourne and 
Mornington Peninsula Shire.   
The case-control component of the Beating Buruli in Victoria project is being conducted by 
Barwon Health and the CSIRO, with support from the other project partners. It aims to identify 
modifiable behavioural and environmental factors that may be associated with Buruli ulcer in 
Victoria, and to provide new information about the presence of Mycobacterium ulcerans in the 
environment of affected areas. Data for the study will be collected through phone-based 
interviews and residential environmental surveys. 
The purpose of the participant information materials was to provide potential study 
participants with understandable information on Buruli ulcer and the case-control study to 
allow them to make an informed decision on whether to participate. 
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Appendix B 
Summary of Teaching Activities 
This appendix contains three teaching activities that I developed and delivered during the 
MAE: 
1. A short introductory lecture on data visualisation, presented to the first-year 2019 
MAE cohort at our third courseblock in March 2019. This lecture was prepared and 
presented alongside fellow 2018 cohort members Sophie Bowman-Derrick and 
Caroline Taunton. We had originally planned to include a practical demonstration of 
how to set up and visualise surveillance data using Microsoft PowerBI. Due to 
unforeseen technical issues with the PC in the tutorial room, we could only 
demonstrate the finished product. Feedback from the participants in the lecture was 
generally positive, with some expected negative responses regarding the technical 
issues in the PowerBI demonstration. A lesson from this experience is to always check 
prior to a lecture that the IT equipment available at the venue is compatible with the 
programs you plan to use. 
 
2. An introductory lecture on the basics of social network analysis for infectious diseases. 
I was invited by the MAE staff to give this lecture to the 2018 cohort at the third 
courseblock in March 2019. As my own experience with social network analysis 
methods was limited (I had recently applied the concepts in one of my projects), I 
decided it was best to give a brief and straightforward overview, which would allow 
participants to reflect on how they may be able to make use of social network analysis 
in their own work. Although formal feedback on the lecture was not sought, anecdotal 
feedback from participants and MAE staff was positive.  
 
3. A “Lesson from the Field” based on the epidemiological challenges of investigating 
tuberculosis clusters and outbreaks. I developed the lesson materials and distributed 
them to the participants; fellow 2018 MAE cohort members Stephen Harfield, Anthea 
Katelaris and Tamara Riley. Participants were asked to review the background reading 
and complete the exercises before the lesson. I facilitated the lesson via Zoom on 17 
April 2019, where we discussed the participants responses to the exercises and 
recapped the key learnings. Feedback from the lesson was very positive, and 
participants enjoyed applying what they had learned in the background reading to the 
scenario-based exercises.  
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Lesson from the Field  
Tuberculosis in Australia: Epidemiological challenges in cluster 
and outbreak investigations 
Presented on 17 April 2019 
Participants – Stephen Harfield, Anthea Katelaris, Tamara Riley 
 
1. Learning Objectives 
By the end of this lesson you will be able to: 
1. Understand the basics of TB transmission. 
2. Understand the common surveillance methods for detecting TB clusters. 
3. Define and apply the criteria for declaring a TB cluster/outbreak. 
4. Develop a robust cluster/outbreak case definition. 
5. Estimate the infectious period for cases. 
2. Required Reading 
Please read over the introductory material in this document and familiarise yourself with the 
following two papers (sent along with this lesson): 
Dheda K, Barry C, Maartens G. Tuberculosis. The Lancet. 2016;387(10024):1211-26 – this short 
review article provides a good overview of TB.  
Denholm J, Coulter C, Bastian I. Defining a tuberculosis cluster or outbreak. Commun Dis Intell 
Q Rep. 2016;40(3):E356-e9. 
3. Exercises 
After completing the required reading, work through exercises 1, 2 and 3. Please send your 
completed exercises to shaun.coutts@anu.edu.au by 15 April 2019 and we will discuss at the 
LFF video conference at 3PM on 17 April 2019 (details TBA). 
4. Tuberculosis – a (very) brief overview 
Tuberculosis (TB) in humans is caused by infection with one of the bacteria in the 
Mycobacterium tuberculosis complex (MTC). Most TB cases are caused by Mycobacterium 
tuberculosis. Other mycobacteria in the MTC that can cause tuberculosis in humans include M. 
bovis and M. africanum. 
A person with infectious TB disease (e.g. pulmonary or laryngeal TB) can forcefully expel M. 
tuberculosis in droplet nuclei when they cough, sneeze, speak or sing. Droplet nuclei can remain 
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suspended in the air for extended periods, depending on the environment. Transmission can 
occur when another person inhales these droplet nuclei into their lungs. 
Four key factors influence whether a person exposed to an infectious TB case will become 
infected: 
1. The infectiousness of the case (e.g. a case with untreated pulmonary TB is highly 
infectious). 
2. The susceptibility of the exposed individual (immune status due to age, comorbidities 
etc.).  
3. The duration, frequency and nature of the exposure (frequent prolonged exposure 
increases the risk). 
4. The environment in which exposure occurred (infection is more likely to occur in 
closed environments). 
Once infection begins, the immune system in most people can control and contain the TB 
bacteria, although it may have already spread to other parts of the body via the lymphatic 
system. These people are said to have latent TB infection (LTBI) and are not considered TB 
cases.  
People with LTBI are not infectious but may later develop active TB disease and become 
infectious. This may occur after a short period, or years to decades after their initial exposure 
and infection. This variable latency period is one of the things that makes TB outbreak 
investigation challenging. 
TB is a notifiable disease in all Australian states and territories. Confirmed cases are notified to 
health authorities based on the following CDNA case definition, which requires either 
laboratory definitive OR clinical evidence:1 
Laboratory definitive evidence  
1. Isolation of Mycobacterium tuberculosis complex (M. tuberculosis, M. bovis or M. 
africanum, excluding M. bovis var BCG) by culture. 
OR 
2. Detection of M. tuberculosis complex by nucleic acid testing EXCEPT where this is likely to be 
due to previously treated or inactive disease. 
Clinical evidence 
1. A clinician experienced in tuberculosis makes a clinical diagnosis of tuberculosis, including 
clinical follow-up assessment to ensure a consistent clinical course. 
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5. Detecting TB clusters 
TB clusters are primarily detected by one or more of the following methods:2 
Case-based surveillance - the detection of an increase in cases (beyond what would normally 
be expected) in a geographic area, community or demographic group over a certain period. 
This may occur at the surveillance level (e.g. identified by a TB epidemiologist) or at the 
frontline (e.g. identified by TB nurses or clinicians in the community). 
Genomic surveillance – in Australian health departments and public health laboratories the 
two most commonly used methods on TB clinical isolates for genomic surveillance are the 
mycobacterial interspersed repetitive unit-variable number tandem repeat typing 
scheme (MIRU-VNTR) and whole genome sequencing (WGS). These methods identify closely 
related isolates and can prompt further investigation of links between genomically-related 
cases that may not have been apparent based on other surveillance data. Both methods 
require a culture from a clinical specimen – this is not always available for every case. 
TB contact investigations - Contact investigations are undertaken to identify people exposed 
to an infectious TB case, to assess them for infection, and to provide treatment as appropriate. 
Contacts are prioritised for investigation based on their risk of infection. Contact investigation 
may identify newly infected persons (i.e. infected by the case that prompted the investigation) 
or identify a possible source case. 
6. Defining TB clusters and outbreaks 
In Australia, the definitions for TB clusters and outbreaks have been defined in a policy paper 
by the National Tuberculosis Advisory Committee (NTAC) as follows:3 
Cluster - 2 or more active cases with identified epidemiological links and the same genotype 
as defined by the method used. 
Probable cluster - 2 or more active cases with identified epidemiological links where 
genotyping is not feasible or the genetic variability between isolates recovered from cases is 
minimal, defined as no more than 1 locus variance for MIRU-typing or as advised by expert 
analysis for WGS. 
Possible cluster - 2 or more active cases with the same genotype as defined by the method 
used where temporal and geospatial association is plausible but no direct epidemiological 
link is identified. 
Outbreak - a cluster that includes 3 or more active cases with evidence of serial transmission 
(i.e. two or more of the cases have transmitted disease) 
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The index case is the first case identified in cluster or outbreak. This may be different to a 
source case; a person identified as being responsible for transmitting TB to the other cases in 
the cluster or outbreak. 
7. Developing a TB cluster case definition 
As with any cluster or outbreak investigation, it is important to develop robust case definitions. 
TB cluster and outbreak case definitions usually include the following elements: 
1. Information about the location or place (e.g. geographic area – could be broad like a 
state or city or narrow like a boarding house or workplace). 
2. Characteristics about the affected persons (e.g. demographic characteristics, activities, 
behaviours, lifestyle, community).  
3. Information about the time during which the outbreak occurred (usually start of the 
infectious period if there is a suspected source case or may go back further if this is 
unknown). 
4. TB genotype information if available. 
The person, place and time elements are often categorised together as “epi links”. 
As it is not always possible to assemble all elements for each case (at least not immediately), 
cases are often further classified into “Possible”, “Probable” and “Definite” cases.  
8. Estimating the infectious period for a cluster/outbreak case 
Due to the nature and course of TB disease, it is often impossible to determine the start of a 
case’s infectious period. 
Key clinical details can be used to estimate the infectious period. These are approximate date 
of symptoms onset and diagnosis, sputum smear results (smear positive cases are generally 
highly infectious) and radiographic results (the presence of lung cavities suggests prolonged 
illness and infectiousness). 
The US CDC recommends the following guideline for the estimation of infectious periods, 
based on expert opinion.4 This guideline suggests that (generally) a case’s infectious period can 
be estimated to end after two weeks of appropriate treatment. 
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TB 
Symptoms 
Sputum 
Smear 
Positive 
Cavitary 
Chest 
Radiograph 
Recommended start of infectious period 
Yes No No 
3 months before symptom onset or first positive 
finding consistent with TB disease (whichever is 
longer) 
Yes Yes Yes 
3 months before symptom onset or first positive 
finding consistent with TB disease (whichever is 
longer) 
No No No 4 weeks before date of diagnosis 
No Yes Yes 
3 weeks before first positive finding consistent with 
TB disease 
 
9. References 
1. Australian Government Department of Health. Tuberculosis case definition Canberra: 
Australian Government; 2011. Available from: 
http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-nndss-casedefs-
cd_tb.htm. 
2. Victorian Department of Health and Human Services. Management, control and 
prevention of tuberculosis. Guidelines for health care providers. Melbourne: Victorian 
Government; 2015. 
3. Denholm J, Coulter C, Bastian I. Defining a tuberculosis cluster or outbreak. Commun 
Dis Intell Q Rep. 2016;40(3):E356-e9. 
4. Centers for Disease Control and Prevention. Guidelines for the investigation of 
contacts of persons with infectious tuberculosis. Recommendations from the National 
Tuberculosis Controllers Association and CDC. MMWR Recommendations and reports : 
Morbidity and mortality weekly report Recommendations and reports. 2005;54(Rr-15):1-47. 
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Task 1. Cluster / Outbreak Definition 
Having read the NTAC definitions, for each of these scenarios consider: 
1. Would you classify it is a cluster? Probable cluster? Possible cluster?  
2. An outbreak?  
3. Why or why not? What other information would be useful? 
4. What challenges have you noticed in classifying these scenarios? 
5. Do you think it is important to differentiate a TB cluster from a TB outbreak? 
Scenario 1. 
A six-year-old child is diagnosed with TB of the lymph nodes at a hospital in inner-metropolitan 
Melbourne. No clinical isolate is available from the child for genotyping.  
The TB team investigate the household contacts of the case. They find: 
• The case’s father and teenage sister have latent TB infections.  
• The case’s stepmother refuses to provide a specimen or be tested, but the father 
reports that she has been coughing for at least two months and appears to have has 
lost some weight. 
Scenario 2. 
Janice is a 2-month-old child who has been clinically diagnosed with pulmonary TB in rural 
Tasmania. This area of Tasmania normally reports less than one case of TB per year on 
average.  
Contact investigation by the TB team find that Janice’s uncle Barry also has active pulmonary 
TB disease. He normally lives in WA but is in between jobs so has been living with the family in 
Tasmania for the past five months, working on perfecting his home-brew recipes. He is more 
than happy to produce a sputum specimen for culture and sequencing. 
As an infant, Janice is unable to produce sputum, so no culture is available for genotyping.  
Scenario 3. 
Harry, a 32-year-old Vietnam-born man, is diagnosed with active pulmonary TB in Sydney. 
Following a contact investigation of his household contacts, his three-year-old son is also 
found to have active TB disease.  
Harry’s employer, SuperCon Semiconductors Pty Ltd, contacts the TB team. Harry has told 
them he has TB and they are worried that he may have exposed his co-workers. They report 
that Harry usually works in a small enclosed room assembling semiconductors along with nine 
colleagues. The TB team decide to conduct a screening session at the workplace. 
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Six of Harry’s colleagues agree to be screened for TB. The other three aren’t too fussed and 
just want to see how things pan out. Screening results show one of Harry’s colleagues, Boris, 
has active TB. The rest are negative.  
Specimens are obtained for culture and WGS from all active cases – they are indistinguishable 
on WGS. With these results in hand, the TB epi searches the surveillance database for other 
cases with the same sequence – there is one case from two months ago, a 26-year-old dentist 
who practices at Bright White Dental Clinic in the same suburb as Supercon Semiconductors.  
The TB team ask the two workplace cases when they last visited a dentist. Harry hasn’t been to 
the dentist in at least 12 years. Boris recently had a gold crown fitted at Bright White Dental 
Clinic but can’t recall the dentist’s name. 
Task 2. Cluster Case Definition  
Bayside Public Health Unit’s TB team have asked you, as a respected MAE Scholar, to assist in a 
suspected TB outbreak investigation as their regular TB epi has taken some unexpected leave.  
Sorting through the sheets of paper on the epi’s desk, you find they have drafted up an 
outbreak case definition: 
• A definite case is defined as a TB case notified to Bayside Public Health Unit from 1 
January 2017, meeting the national confirmed TB case definition, who was 
epidemiologically linked to other cases within the outbreak and had a genomic profile 
matching the outbreak strain. 
• A probable case meets the criteria for a definite case but has an unknown genomic 
profile.  
• A possible case meets the criteria for a definite case but has no established 
epidemiological link to another case in the outbreak. 
The only other information you can find on the desk is that the outbreak genotype is believed 
to be GT101. 
ID 
Date 
Notified 
Classification Age Gender Genotype Case notes 
1 
10/10/2018  17 F GT101 Year 12 student at Bayside 
Grammar School. Failing 
chemistry. 
2 
08/05/2018  23 F GT101 Science student at Bayside 
University. Lives in a share house.  
3 07/02/2018  21 M GT101 Unable to contact case. 
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4 
22/07/2018  55 F Pending Manager at Bayside UniHouse at 
Bayside Uni. 
5 
09/01/2018  23 M GT101 Arts student at Bayside University. 
Lives at Bayside UniHouse. 
6 
07/08/2019  28 F GT473 PhD student at Bayside University. 
Lives off-campus. 
7 
25/12/2018  33 F Pending MPH student at Bayside 
University. Lives off-campus. 
8 22/01/2019  1 F N/A Child of case #7. 
9 15/11/2016  62 M Pending Maintenance worker for Bayside 
UniHouse. Collects stamps. 
 
1. Looking at the available information, what would you consider valid “epi links” for this 
investigation? 
2. Classify the eleven cases in the line list based on your case definition. 
3. What other information would be useful in classifying the cases? 
Task 3. Estimating Infectious Periods 
Based on the information in section 8, estimate the infectious period for the following cases.  
Assume the first positive finding consistent TB disease is the same as the date diagnosed. 
ID 
Date  
Diagnosed 
TB  
Symptoms 
Smear 
Positive 
Cavitary 
CXR 
Symptom 
Onset 
Treatment 
Start Date 
Infectious  
Start 
Infectious 
End 
1 08/10/2018 No No No ? 10/10/2018   
2 08/05/2018 Yes Yes Yes 02/04/2018 10/05/2018   
3 01/02/2018 No Yes Yes ? 10/02/2018   
4 21/07/2018 Yes No No 19/03/2018 25/07/2018   
5 07/01/2018 No No No ? 09/01/2018   
 
1. What other considerations might alter your estimation for the start of a case’s infectious 
period? 
2. What about the end of a cases’ infectious period? 
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Appendix C 
SaMELFS Samoa Mosquito Survey and Molecular Xenomonitoring 
Study 
 
This appendix contains a short report on my experience in Samoa as a team 
leader/epidemiologist for the SaMELFS Samoa mosquito survey and molecular xenomonitoring 
study between 14 June 2019 and 30 June 2019, and a copy of an online news article I was 
invited to write for publication on the ANU Research School of Population Health and MAE 
program websites.   
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Background 
Lymphatic filariasis (LF) is mosquito-borne neglected tropical disease caused by filarial worms. 
In 1997 the World Health Organization called for the global elimination of LF as a public health 
problem by 2020, using a strategy of annual mass drug administration (MDA) - single dose 
diethylcarbamazine (DEC) plus albendazole for the entire at-risk population. In 2017, following 
safety and efficacy trials, the WHO endorsed the addition of ivermectin to the MDA regimen 
(triple drug MDA with ivermectin, DEC and albendazole, (IDA)) for countries that have ongoing 
transmission despite implementing the recommended rounds of MDA. Despite significant 
progress toward the elimination goal in some countries, it will not be achieved globally by 
2020.  
Wuchereria bancrofti is the causative parasite of LF in Samoa, with Aedes polynesiensis as the 
primary vector. Despite completing multiple rounds of MDA in the past, recent surveillance 
indicated ongoing transmission. Samoa completed a first round of IDA in August 2018, with a 
second round scheduled for December 2019.  
Surveillance and Monitoring to Eliminate Lymphatic Filariasis and Scabies from Samoa 
(SaMELFS Samoa) is an ANU-led project that aims to develop a monitoring and evaluation 
strategy that can be used in Samoa to determine when the risk of LF transmission has been 
sufficiently reduced to stop IDA with little to no risk of transmission resurgence. The principal 
investigators for SaMELFS Samoa are Colleen Lau (ANU), Sarah Sheridan (University of New 
South Wales), Patricia Graves (James Cook University) and Robert Thomsen (Samoa Ministry of 
Health). SaMELFS Samoa is funded by the Task Force for Global Health (USA) and the Bill and 
Melinda Gates Foundation. 
The two main components of SaMELFS Samoa are a human seroprevalence study and a 
mosquito survey/molecular xenomonitoring study. The primary aims of the mosquito survey 
are to investigate associations between the presence of PCR-positive mosquitoes and the 
seroprevalence of LF in humans, and to assess the usefulness of molecular xenomonitoring 
(MX) as an early and sensitive indicator of LF transmission. 
Role 
I was offered the opportunity to work as a team leader for the SaMELFS Samoa Mosquito 
Survey from 14-30 June 2019 through my academic supervisor Associate Professor Colleen Lau 
and MAE colleague Brady McPherson (Australian Defence Force Malaria and Infectious Disease 
Institute). I had previously worked with several of the SaMELFS Samoa investigators in 2017 to 
publish a paper on LF in American Samoa based on secondary data, so I was keen to gain some 
first-hand field experience in an LF surveillance and elimination program. 
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During my time in-country the SaMELFS Samoa Mosquito Survey team generally consisted of 
myself (team leader/epidemiologist), two entomologists, and three Samoan Red Cross staff. 
We were based at a hotel in Apia, where the team had established a small entomology field 
laboratory and office.  
MX was conducted at a total of 35 primary sampling units (PSUs) during the survey which 
consisted of one or two villages, depending on village size. Mosquito trapping at the 14 PSUs 
was completed during my time in-country. In each PSU, 15 households were sampled using 
Google Earth. Two teams (consisting of an Australian and a Samoan team member) operated 
simultaneously in different PSUs, using printed maps and smartphones to locate sampled 
households. If a household was unoccupied, or was not a household, it was replaced with the 
next-closest household. Biogents Sentinel mosquito traps (BG traps), baited with BG-Lures, 
were set at each household for a 48-hour period. The traps were checked, and the battery and 
catch net changed, after 24 hours.  
On a practical level, this meant that every second day we would collect second catches from 
traps in one village and relocate the traps to a new village on the same day. As we were unable 
to set or check traps in villages on Sundays due to cultural considerations, traps had to be set 
as early as possible on a Saturday morning, checked and battery-swapped as late as possible 
on Saturday afternoon/evening (first catch) and then checked and collected (second catch) as 
early as possible on Monday morning. 
Each catch net (two from each trap over the 48-hour period) was sorted in the lab by the 
entomologists. All male mosquitoes and other insects were discarded. The remaining female 
mosquitoes were sorted into the following categories: 
▪ Aedes polynesiensis  
▪ Aedes aegypti 
▪ Aedes albopictus 
▪ Aedes upolensis 
▪ Aedes (Finlaya) spp. 
▪ Aedes spp. (other) 
▪ Culex quinquefasciatus  
▪ Culex spp. (other) 
▪ Other 
Sorted mosquitoes were subsequently pooled into tubes of ≤25 mosquitoes of the same 
species from the same household location, dehydrated in an oven to prevent deterioration and 
packed for shipment to Smith College, USA for PCR testing.  
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All data collected during the survey were entered directly into the Secure Data Kit (SDK) 
smartphone app in the field and the lab, using a separate electronic data collection form for 
each step – setting, sorting and pooling. Data were automatically uploaded from the 
smartphones onto the secure SDK cloud-based database. I regularly checked the data on the 
SDK database for errors and inconsistences using an R script, correcting these using the web-
based SDK interface as necessary. Weekly progress reports were compiled weekly and emailed 
to the principal investigators. 
As a team leader for the survey I was also responsible for the day-to-day management of the 
project, ensuring that village visits, finances, vehicles, accommodation, consumables and other 
logistics were organised. 
Lessons  
My time with the SAMELFS-Samoa study was a valuable experience in conducting operational 
research in the field. It was also a great introduction to the day-to-day management of a field 
project in another country – from organising our consumables, to the payment of Samoan staff 
and undertaking protracted negotiations over the cost of rental vehicle repairs. This all had to 
be done while respecting the context and customs of the country in which we were working. 
Although I had some experience in mosquito trapping and the use of BG traps in Victoria, it 
was useful to learn more about the ideal positioning of traps, taking into consideration the 
tropical weather, accessibility for subsequent collections and dangers to the trap (primarily, 
curious local children and village dogs). 
Despite the SDK smartphone-based electronic data management system massively reducing 
the amount of paper-based data recording, entry and errors in the field, there is still always 
the possibility (or inevitability) that somebody will enter the wrong number or press the wrong 
option. The importance of good data management in the field became clear as I ran the 
regular data checks – it was obviously much easier and preferable to pick up minor human 
errors in trap numbers, locations, species counts and so forth while the data were fresh than 
to have to deal with the errors in a dataset when preparing for an analysis.  
Importantly I managed to learn a bit about the nation of Samoa, including a few useful words 
of Samoan. I couldn’t think of a better place for my first overseas field epidemiology 
experience - it is a beautiful country full of welcoming people, to which I would love to return 
in the future. 
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Implications 
The results of this mosquito survey and xenomonitoring study will be used to inform the 
refinement of LF surveillance and monitoring methods in Samoa, elsewhere in the Pacific, and 
beyond. Colleague from the project will be presenting results from the study at the 2019 
Coalition for Operational Research on Neglected Tropical Diseases (COR-NTD) meeting in 
Washington DC, USA and the 2019 American Society of Tropical Medicine and Hygiene annual 
meeting in Maryland, USA. 
As more countries complete MDA and move toward LF elimination it is increasingly important 
to have sensitive, validated and cost-effective tools to monitor low-level LF transmission and 
possible resurgence. Molecular xenomonitoring, if it can be used as a sensitive non-invasive 
proxy for infection in the human population, may become a key component in the surveillance 
for LF as endemic countries move toward elimination.  
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